NCT03316404View on ClinicalTrials.gov

Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response

CompletedOBSERVATIONAL
Enrollment

1,168

Participants

Timeline

Start Date

November 7, 2017

Primary Completion Date

February 24, 2020

Study Completion Date

February 25, 2020

Conditions
Multiple SclerosisMS
Trial Locations (1)

90220

DxTerity Diagnostics, Compton

Sponsors
All Listed Sponsors
lead

DxTerity Diagnostics

INDUSTRY

NCT03316404 - Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response | Biotech Hunter | Biotech Hunter